HEADER TRANSFERASE/TRANSFERASE SUBSTRATE 19-APR-02 1GY3 TITLE PCDK2/CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE SUBSTRATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CELL DIVISION PROTEIN KINASE 2; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: P33 PROTEIN KINASE; COMPND 5 ENGINEERED: YES; COMPND 6 OTHER_DETAILS: PHOSPHORYLATED ON THR160; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: CYCLIN A2; COMPND 9 CHAIN: B, D; COMPND 10 FRAGMENT: RESIDUES 175-432; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: SUBSTRATE PEPTIDE; COMPND 14 CHAIN: E, F; COMPND 15 ENGINEERED: YES; COMPND 16 OTHER_DETAILS: SEQUENCE HHASPRK SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: B834 (DE3) PLYSS; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PGEX; SOURCE 9 OTHER_DETAILS: CDK2 WAS CO-EXPRESSED WITH CAK1 - PRODUCE THR160- SOURCE 10 PHOSPHO-CDK2; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: B834 (DE3) PLYSS; SOURCE 18 EXPRESSION_SYSTEM_VECTOR: PET21D; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES; SOURCE 21 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 22 ORGANISM_TAXID: 32630 KEYWDS TRANSFERASE-TRANSFERASE SUBSTRATE COMPLEX, CELL CYCLE REGULATORY KEYWDS 2 PROTEIN KINASE, THR160-PHOSPHO-CYCLIN DEPENDENT PROTEIN KINASE 2 IN KEYWDS 3 ASSOCIATION WITH CYCLIN A, TRANSFERASE- TRANSFERASE SUBSTRATE KEYWDS 4 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.COOK,E.D.LOWE,E.D.CHRYSINA,V.T.SKAMNAKI,N.G.OIKONOMAKOS,L.N.JOHNSON REVDAT 7 23-OCT-24 1GY3 1 REMARK REVDAT 6 13-DEC-23 1GY3 1 REMARK LINK REVDAT 5 15-MAY-19 1GY3 1 REMARK LINK ATOM REVDAT 4 13-JUL-11 1GY3 1 VERSN REVDAT 3 24-FEB-09 1GY3 1 VERSN REVDAT 2 06-JUN-02 1GY3 1 JRNL REVDAT 1 29-APR-02 1GY3 0 JRNL AUTH A.COOK,E.D.LOWE,E.D.CHRYSINA,V.T.SKAMNAKI,N.G.OIKONOMAKOS, JRNL AUTH 2 L.N.JOHNSON JRNL TITL STRUCTURAL STUDIES ON PHOSPHO-CDK2/CYCLIN A BOUND TO JRNL TITL 2 NITRATE, A TRANSITION STATE ANALOGUE: IMPLICATIONS FOR THE JRNL TITL 3 PROTEIN KINASE MECHANISM JRNL REF BIOCHEMISTRY V. 41 7301 2002 JRNL REFN ISSN 0006-2960 JRNL PMID 12044161 JRNL DOI 10.1021/BI0201724 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH N.R.BROWN,M.E.M.NOBLE,J.A.ENDICOTT,L.N.JOHNSON REMARK 1 TITL THE STRUCTURAL BASIS FOR SPECIFICITY OF SUBSTRATE AND REMARK 1 TITL 2 RECRUITMENT PEPTIDES FO CYCLIN-DEPENDENT KINASES REMARK 1 REF NAT.CELL BIOL. V. 1 438 1999 REMARK 1 REFN ISSN 1465-7392 REMARK 1 PMID 10559988 REMARK 1 DOI 10.1038/15674 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 84.4 REMARK 3 NUMBER OF REFLECTIONS : 41578 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.313 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9046 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 162 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.420 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.390 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GY3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-APR-02. REMARK 100 THE DEPOSITION ID IS D_1290009686. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.934 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45572 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 84.4 REMARK 200 DATA REDUNDANCY : 7.000 REMARK 200 R MERGE (I) : 0.14300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 40.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.48700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE, REFMAC REMARK 200 STARTING MODEL: 1QMZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS WERE GROWN BY VAPOUR REMARK 280 DIFFUSION AT 4C FROM SOLUTIONS CONTAINING 10 MG/ML PCDK2/CYCLIN REMARK 280 A, 100 MM HEPES PH7.0, 2 MM SUBSTRATE PEPTIDE, 1MM ADP, 1.0 M REMARK 280 LI2SO4. CRYSTALS WERE TRANSFERRED TO 20%PEG 8K, 100 MM HEPES PH REMARK 280 7.0, 10 MM SUBSSTRATE PEPTIDE, 5 MM MG(NO3)2, PH 7.00, VAPOR REMARK 280 DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 75.35500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 82.05000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 75.35500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 82.05000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 0 REMARK 465 ARG A 297 REMARK 465 LEU A 298 REMARK 465 SER C 0 REMARK 465 ARG C 297 REMARK 465 LEU C 298 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 2001 O HOH B 2012 2.00 REMARK 500 O ALA C 116 OG SER C 120 2.01 REMARK 500 ND1 HIS D 321 OG SER D 375 2.05 REMARK 500 N LYS D 288 O HOH D 2023 2.07 REMARK 500 N VAL C 69 O HOH C 2009 2.08 REMARK 500 OH TYR B 178 O HOH B 2003 2.12 REMARK 500 OG SER F 5 N NO3 C 1300 2.12 REMARK 500 NH2 ARG C 150 O GLU D 268 2.14 REMARK 500 CG GLU B 224 O HOH B 2009 2.17 REMARK 500 N THR D 383 OG SER D 386 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 2010 O HOH C 2011 3546 2.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 92 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 TYR A 159 O - C - N ANGL. DEV. = -14.1 DEGREES REMARK 500 ASP A 235 CB - CG - OD2 ANGL. DEV. = 7.0 DEGREES REMARK 500 ASP A 247 CB - CG - OD2 ANGL. DEV. = 5.4 DEGREES REMARK 500 ASP C 92 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 TYR C 159 O - C - N ANGL. DEV. = -10.6 DEGREES REMARK 500 TPO C 160 CA - C - N ANGL. DEV. = -31.3 DEGREES REMARK 500 ASP C 185 CB - CG - OD2 ANGL. DEV. = 7.0 DEGREES REMARK 500 ASP C 206 CB - CG - OD2 ANGL. DEV. = 5.7 DEGREES REMARK 500 ASP C 247 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 ASP D 305 CB - CG - OD2 ANGL. DEV. = 6.2 DEGREES REMARK 500 ASP D 343 CB - CG - OD2 ANGL. DEV. = 5.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 7 -78.19 -105.15 REMARK 500 GLU A 12 106.51 -162.41 REMARK 500 THR A 14 -77.85 -69.80 REMARK 500 ASP A 38 -45.45 64.08 REMARK 500 THR A 39 172.11 68.01 REMARK 500 THR A 41 -103.59 -111.38 REMARK 500 LEU A 58 58.23 -117.33 REMARK 500 ASN A 62 43.82 -106.00 REMARK 500 THR A 72 -159.64 -66.14 REMARK 500 ASP A 127 40.63 -165.07 REMARK 500 THR A 137 11.28 -68.72 REMARK 500 ASP A 145 78.14 44.28 REMARK 500 TYR A 159 -152.74 -110.56 REMARK 500 GLU A 162 77.29 -60.60 REMARK 500 VAL A 164 139.26 75.99 REMARK 500 SER A 181 -150.70 -148.75 REMARK 500 VAL B 197 -74.63 -36.02 REMARK 500 LEU B 262 -75.81 -49.05 REMARK 500 LEU B 263 -71.59 -35.81 REMARK 500 ALA B 264 -38.55 -35.38 REMARK 500 THR B 303 56.93 36.16 REMARK 500 PHE B 304 8.13 48.30 REMARK 500 PRO B 324 -155.90 -91.67 REMARK 500 TRP B 372 101.36 -41.51 REMARK 500 VAL C 7 -60.21 -103.46 REMARK 500 GLU C 8 140.46 -170.37 REMARK 500 ASP C 38 -109.82 77.41 REMARK 500 THR C 39 153.12 144.54 REMARK 500 THR C 41 -105.12 -131.32 REMARK 500 PRO C 45 153.32 -48.85 REMARK 500 GLU C 57 30.92 -143.99 REMARK 500 THR C 72 -150.90 -72.12 REMARK 500 HIS C 121 52.43 -108.06 REMARK 500 ARG C 122 50.31 32.38 REMARK 500 ARG C 126 7.32 86.12 REMARK 500 ASP C 127 52.38 -161.37 REMARK 500 VAL C 164 144.74 77.28 REMARK 500 SER C 181 -153.98 -161.62 REMARK 500 ARG C 199 -0.43 67.75 REMARK 500 TRP C 227 74.45 -155.91 REMARK 500 PHE C 248 1.92 -68.25 REMARK 500 LEU C 281 -34.10 -34.84 REMARK 500 CYS D 193 34.62 -95.52 REMARK 500 VAL D 197 -60.72 -25.47 REMARK 500 THR D 303 45.64 35.79 REMARK 500 PHE D 304 14.68 53.43 REMARK 500 ALA D 307 56.93 -67.99 REMARK 500 TYR D 347 -14.31 -39.97 REMARK 500 GLN D 370 -162.92 -73.08 REMARK 500 TRP D 372 110.67 -32.05 REMARK 500 REMARK 500 THIS ENTRY HAS 55 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 TYR A 159 -17.97 REMARK 500 TPO A 160 11.81 REMARK 500 TYR C 159 17.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 ATP C 1298 REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1298 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 132 OD1 REMARK 620 2 ASP A 145 OD2 80.8 REMARK 620 3 ATP A1297 O2A 74.4 87.4 REMARK 620 4 ATP A1297 O3B 142.4 100.4 68.1 REMARK 620 5 NO3 A1299 O3 119.6 64.8 144.0 93.7 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG C1299 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN C 132 OD1 REMARK 620 2 ASP C 145 OD2 92.1 REMARK 620 3 ATP C1298 O2A 108.3 77.5 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 1297 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 1298 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NO3 A 1299 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 1433 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL C 1297 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP C 1298 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG C 1299 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NO3 C 1300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF SUBSTRATE PEPTIDE REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF SUBSTRATE PEPTIDE REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AQ1 RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 STAUROSPORINE REMARK 900 RELATED ID: 1B38 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1B39 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 PHOSPHORYLATED ON THR 160 REMARK 900 RELATED ID: 1BUH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITHCELL CYCLE- REMARK 900 REGULATORY PROTEIN CKSHS1 REMARK 900 RELATED ID: 1CKP RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 PURVALANOL B REMARK 900 RELATED ID: 1DI8 RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH 4- REMARK 900 [3- HYDROXYANILINO]-6,7-DIMETHOXYQUINAZOLINE REMARK 900 RELATED ID: 1DM2 RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR REMARK 900 HYMENIALDISINE REMARK 900 RELATED ID: 1E1V RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 REMARK 900 RELATED ID: 1E1X RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU6027 REMARK 900 RELATED ID: 1E9H RELATED DB: PDB REMARK 900 THR 160 PHOSPHORYLATED CDK2 - HUMAN CYCLIN A3 COMPLEX WITH THE REMARK 900 INHIBITOR INDIRUBIN-5- SULPHONATE BOUND REMARK 900 RELATED ID: 1F5Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO REMARK 900 HUMAN CYCLIN DEPENDANT KINASE 2 REMARK 900 RELATED ID: 1FIN RELATED DB: PDB REMARK 900 CYCLIN A - CYCLIN-DEPENDENT KINASE 2 COMPLEX REMARK 900 RELATED ID: 1FQ1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) INCOMPLEX REMARK 900 WITH PHOSPHO-CDK2 REMARK 900 RELATED ID: 1FVT RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH AN REMARK 900 OXINDOLE INHIBITOR REMARK 900 RELATED ID: 1FVV RELATED DB: PDB REMARK 900 THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR REMARK 900 RELATED ID: 1G5S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN REMARK 900 COMPLEX WITH THE INHIBITOR H717 REMARK 900 RELATED ID: 1GIH RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1GII RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1GIJ RELATED DB: PDB REMARK 900 HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4INHIBITOR REMARK 900 RELATED ID: 1HCK RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1HCL RELATED DB: PDB REMARK 900 HUMAN CYCLIN-DEPENDENT KINASE 2 REMARK 900 RELATED ID: 1JST RELATED DB: PDB REMARK 900 PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A REMARK 900 RELATED ID: 1JSU RELATED DB: PDB REMARK 900 P27(KIP1)/CYCLIN A/CDK2 COMPLEX REMARK 900 RELATED ID: 1JSV RELATED DB: PDB REMARK 900 THE STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2) INCOMPLEX WITH 4- REMARK 900 [(6-AMINO-4- PYRIMIDINYL)AMINO]BENZENESULFONAMIDE REMARK 900 RELATED ID: 1JVP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CDK2 (UNPHOSPHORYLATED) INCOMPLEX WITH REMARK 900 PKF049-365 REMARK 900 RELATED ID: 1QMZ RELATED DB: PDB REMARK 900 PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX REMARK 999 REMARK 999 SEQUENCE REMARK 999 VAL B 175, N-TERMINAL DELETION OF RESIDUES 1-174 ENGINEERED REMARK 999 IN EXPRESSION CONSTRUCT REMARK 999 VAL D 175, N-TERMINAL DELETION OF RESIDUES 1-174 ENGINEERED REMARK 999 IN EXPRESSION CONSTRUCT REMARK 999 MODRES: 1GY3 TPO A 160() THR160 HAS BEEN PHOSPHORYLATED BY REMARK 999 COEXPRESSION WITH CAK1 REMARK 999 MODRES: 1GY3 TPO C 160() THR160 HAS BEEN PHOSPHORYLATED BY REMARK 999 COEXPRESSION WITH CAK1 DBREF 1GY3 A 0 0 PDB 1GY3 1GY3 0 0 DBREF 1GY3 A 1 296 UNP P24941 CDK2_HUMAN 1 296 DBREF 1GY3 B 175 432 UNP P20248 CGA2_HUMAN 175 432 DBREF 1GY3 C 0 0 PDB 1GY3 1GY3 0 0 DBREF 1GY3 C 1 296 UNP P24941 CDK2_HUMAN 1 296 DBREF 1GY3 D 175 432 UNP P20248 CGA2_HUMAN 175 432 DBREF 1GY3 E 2 8 PDB 1GY3 1GY3 2 8 DBREF 1GY3 F 2 8 PDB 1GY3 1GY3 2 8 SEQRES 1 A 299 SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU SEQRES 2 A 299 GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU SEQRES 3 A 299 THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP SEQRES 4 A 299 THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU SEQRES 5 A 299 ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL SEQRES 6 A 299 LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR SEQRES 7 A 299 LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE SEQRES 8 A 299 MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU SEQRES 9 A 299 ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA SEQRES 10 A 299 PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS SEQRES 11 A 299 PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS SEQRES 12 A 299 LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO SEQRES 13 A 299 VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR SEQRES 14 A 299 ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER SEQRES 15 A 299 THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA SEQRES 16 A 299 GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER SEQRES 17 A 299 GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY SEQRES 18 A 299 THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET SEQRES 19 A 299 PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN SEQRES 20 A 299 ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY SEQRES 21 A 299 ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN SEQRES 22 A 299 LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE SEQRES 23 A 299 PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 B 258 VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR LEU ARG SEQRES 2 B 258 GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY TYR MET SEQRES 3 B 258 LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG ALA ILE SEQRES 4 B 258 LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU TYR LYS SEQRES 5 B 258 LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN TYR ILE SEQRES 6 B 258 ASP ARG PHE LEU SER SER MET SER VAL LEU ARG GLY LYS SEQRES 7 B 258 LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU ALA SER SEQRES 8 B 258 LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA GLU PHE SEQRES 9 B 258 VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS GLN VAL SEQRES 10 B 258 LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU THR PHE SEQRES 11 B 258 ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU THR GLN SEQRES 12 B 258 TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS VAL GLU SEQRES 13 B 258 SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU ILE ASP SEQRES 14 B 258 ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL ILE ALA SEQRES 15 B 258 GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL THR GLY SEQRES 16 B 258 GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR GLY TYR SEQRES 17 B 258 THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP LEU HIS SEQRES 18 B 258 GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN GLN SER SEQRES 19 B 258 ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS GLY VAL SEQRES 20 B 258 SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU SEQRES 1 C 299 SER MET GLU ASN PHE GLN LYS VAL GLU LYS ILE GLY GLU SEQRES 2 C 299 GLY THR TYR GLY VAL VAL TYR LYS ALA ARG ASN LYS LEU SEQRES 3 C 299 THR GLY GLU VAL VAL ALA LEU LYS LYS ILE ARG LEU ASP SEQRES 4 C 299 THR GLU THR GLU GLY VAL PRO SER THR ALA ILE ARG GLU SEQRES 5 C 299 ILE SER LEU LEU LYS GLU LEU ASN HIS PRO ASN ILE VAL SEQRES 6 C 299 LYS LEU LEU ASP VAL ILE HIS THR GLU ASN LYS LEU TYR SEQRES 7 C 299 LEU VAL PHE GLU PHE LEU HIS GLN ASP LEU LYS LYS PHE SEQRES 8 C 299 MET ASP ALA SER ALA LEU THR GLY ILE PRO LEU PRO LEU SEQRES 9 C 299 ILE LYS SER TYR LEU PHE GLN LEU LEU GLN GLY LEU ALA SEQRES 10 C 299 PHE CYS HIS SER HIS ARG VAL LEU HIS ARG ASP LEU LYS SEQRES 11 C 299 PRO GLN ASN LEU LEU ILE ASN THR GLU GLY ALA ILE LYS SEQRES 12 C 299 LEU ALA ASP PHE GLY LEU ALA ARG ALA PHE GLY VAL PRO SEQRES 13 C 299 VAL ARG THR TYR TPO HIS GLU VAL VAL THR LEU TRP TYR SEQRES 14 C 299 ARG ALA PRO GLU ILE LEU LEU GLY CYS LYS TYR TYR SER SEQRES 15 C 299 THR ALA VAL ASP ILE TRP SER LEU GLY CYS ILE PHE ALA SEQRES 16 C 299 GLU MET VAL THR ARG ARG ALA LEU PHE PRO GLY ASP SER SEQRES 17 C 299 GLU ILE ASP GLN LEU PHE ARG ILE PHE ARG THR LEU GLY SEQRES 18 C 299 THR PRO ASP GLU VAL VAL TRP PRO GLY VAL THR SER MET SEQRES 19 C 299 PRO ASP TYR LYS PRO SER PHE PRO LYS TRP ALA ARG GLN SEQRES 20 C 299 ASP PHE SER LYS VAL VAL PRO PRO LEU ASP GLU ASP GLY SEQRES 21 C 299 ARG SER LEU LEU SER GLN MET LEU HIS TYR ASP PRO ASN SEQRES 22 C 299 LYS ARG ILE SER ALA LYS ALA ALA LEU ALA HIS PRO PHE SEQRES 23 C 299 PHE GLN ASP VAL THR LYS PRO VAL PRO HIS LEU ARG LEU SEQRES 1 D 258 VAL PRO ASP TYR HIS GLU ASP ILE HIS THR TYR LEU ARG SEQRES 2 D 258 GLU MET GLU VAL LYS CYS LYS PRO LYS VAL GLY TYR MET SEQRES 3 D 258 LYS LYS GLN PRO ASP ILE THR ASN SER MET ARG ALA ILE SEQRES 4 D 258 LEU VAL ASP TRP LEU VAL GLU VAL GLY GLU GLU TYR LYS SEQRES 5 D 258 LEU GLN ASN GLU THR LEU HIS LEU ALA VAL ASN TYR ILE SEQRES 6 D 258 ASP ARG PHE LEU SER SER MET SER VAL LEU ARG GLY LYS SEQRES 7 D 258 LEU GLN LEU VAL GLY THR ALA ALA MET LEU LEU ALA SER SEQRES 8 D 258 LYS PHE GLU GLU ILE TYR PRO PRO GLU VAL ALA GLU PHE SEQRES 9 D 258 VAL TYR ILE THR ASP ASP THR TYR THR LYS LYS GLN VAL SEQRES 10 D 258 LEU ARG MET GLU HIS LEU VAL LEU LYS VAL LEU THR PHE SEQRES 11 D 258 ASP LEU ALA ALA PRO THR VAL ASN GLN PHE LEU THR GLN SEQRES 12 D 258 TYR PHE LEU HIS GLN GLN PRO ALA ASN CYS LYS VAL GLU SEQRES 13 D 258 SER LEU ALA MET PHE LEU GLY GLU LEU SER LEU ILE ASP SEQRES 14 D 258 ALA ASP PRO TYR LEU LYS TYR LEU PRO SER VAL ILE ALA SEQRES 15 D 258 GLY ALA ALA PHE HIS LEU ALA LEU TYR THR VAL THR GLY SEQRES 16 D 258 GLN SER TRP PRO GLU SER LEU ILE ARG LYS THR GLY TYR SEQRES 17 D 258 THR LEU GLU SER LEU LYS PRO CYS LEU MET ASP LEU HIS SEQRES 18 D 258 GLN THR TYR LEU LYS ALA PRO GLN HIS ALA GLN GLN SER SEQRES 19 D 258 ILE ARG GLU LYS TYR LYS ASN SER LYS TYR HIS GLY VAL SEQRES 20 D 258 SER LEU LEU ASN PRO PRO GLU THR LEU ASN LEU SEQRES 1 E 7 HIS HIS ALA SER PRO ARG LYS SEQRES 1 F 7 HIS HIS ALA SER PRO ARG LYS MODRES 1GY3 TPO A 160 THR PHOSPHOTHREONINE MODRES 1GY3 TPO C 160 THR PHOSPHOTHREONINE HET TPO A 160 11 HET TPO C 160 10 HET ATP A1297 27 HET MG A1298 1 HET NO3 A1299 4 HET GOL B1433 6 HET GOL C1297 6 HET ATP C1298 27 HET MG C1299 1 HET NO3 C1300 4 HETNAM TPO PHOSPHOTHREONINE HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE HETNAM MG MAGNESIUM ION HETNAM NO3 NITRATE ION HETNAM GOL GLYCEROL HETSYN TPO PHOSPHONOTHREONINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 7 ATP 2(C10 H16 N5 O13 P3) FORMUL 8 MG 2(MG 2+) FORMUL 9 NO3 2(N O3 1-) FORMUL 10 GOL 2(C3 H8 O3) FORMUL 15 HOH *162(H2 O) HELIX 1 1 PRO A 45 GLU A 57 1 13 HELIX 2 2 LEU A 87 SER A 94 1 8 HELIX 3 3 PRO A 100 HIS A 121 1 22 HELIX 4 4 LYS A 129 GLN A 131 5 3 HELIX 5 5 ASP A 145 ALA A 149 5 5 HELIX 6 6 THR A 165 ARG A 169 5 5 HELIX 7 7 ALA A 170 LEU A 175 1 6 HELIX 8 8 THR A 182 ARG A 199 1 18 HELIX 9 9 SER A 207 GLY A 220 1 14 HELIX 10 10 GLY A 229 MET A 233 5 5 HELIX 11 11 ASP A 247 VAL A 252 1 6 HELIX 12 12 ASP A 256 LEU A 267 1 12 HELIX 13 13 SER A 276 ALA A 282 1 7 HELIX 14 14 HIS A 283 VAL A 289 5 7 HELIX 15 15 TYR B 178 CYS B 193 1 16 HELIX 16 16 GLY B 198 GLN B 203 1 6 HELIX 17 17 THR B 207 TYR B 225 1 19 HELIX 18 18 GLN B 228 SER B 244 1 17 HELIX 19 19 LEU B 249 GLU B 269 1 21 HELIX 20 20 GLU B 274 THR B 282 1 9 HELIX 21 21 THR B 287 LEU B 302 1 16 HELIX 22 22 THR B 310 PHE B 319 1 10 HELIX 23 23 LEU B 320 GLN B 322 5 3 HELIX 24 24 ASN B 326 ASP B 343 1 18 HELIX 25 25 ASP B 343 LEU B 348 1 6 HELIX 26 26 LEU B 351 THR B 368 1 18 HELIX 27 27 PRO B 373 GLY B 381 1 9 HELIX 28 28 THR B 383 LYS B 400 1 18 HELIX 29 29 ALA B 401 HIS B 404 5 4 HELIX 30 30 GLN B 407 TYR B 413 1 7 HELIX 31 31 LYS B 414 HIS B 419 5 6 HELIX 32 32 GLY B 420 LEU B 424 5 5 HELIX 33 33 PRO C 45 LYS C 56 1 12 HELIX 34 34 LEU C 87 SER C 94 1 8 HELIX 35 35 PRO C 100 HIS C 121 1 22 HELIX 36 36 LYS C 129 GLN C 131 5 3 HELIX 37 37 THR C 165 ARG C 169 5 5 HELIX 38 38 ALA C 170 LEU C 175 1 6 HELIX 39 39 THR C 182 ARG C 199 1 18 HELIX 40 40 SER C 207 GLY C 220 1 14 HELIX 41 41 GLY C 229 MET C 233 5 5 HELIX 42 42 ASP C 247 VAL C 252 1 6 HELIX 43 43 ASP C 256 LEU C 267 1 12 HELIX 44 44 SER C 276 ALA C 282 1 7 HELIX 45 45 HIS C 283 GLN C 287 5 5 HELIX 46 46 VAL D 175 ASP D 177 5 3 HELIX 47 47 TYR D 178 CYS D 193 1 16 HELIX 48 48 THR D 207 TYR D 225 1 19 HELIX 49 49 GLN D 228 MET D 246 1 19 HELIX 50 50 LEU D 249 GLY D 251 5 3 HELIX 51 51 LYS D 252 GLU D 269 1 18 HELIX 52 52 GLU D 274 ILE D 281 1 8 HELIX 53 53 THR D 287 THR D 303 1 17 HELIX 54 54 THR D 310 PHE D 319 1 10 HELIX 55 55 LEU D 320 GLN D 322 5 3 HELIX 56 56 ASN D 326 LEU D 341 1 16 HELIX 57 57 ASP D 343 LEU D 348 1 6 HELIX 58 58 LEU D 351 GLY D 369 1 19 HELIX 59 59 PRO D 373 GLY D 381 1 9 HELIX 60 60 LEU D 387 ALA D 401 1 15 HELIX 61 61 PRO D 402 HIS D 404 5 3 HELIX 62 62 GLN D 407 TYR D 413 1 7 HELIX 63 63 LYS D 414 HIS D 419 5 6 HELIX 64 64 GLY D 420 LEU D 424 5 5 SHEET 1 AA 5 PHE A 4 GLU A 12 0 SHEET 2 AA 5 VAL A 17 ASN A 23 -1 O VAL A 18 N ILE A 10 SHEET 3 AA 5 VAL A 29 ARG A 36 -1 O VAL A 30 N ALA A 21 SHEET 4 AA 5 LYS A 75 GLU A 81 -1 O LEU A 76 N ILE A 35 SHEET 5 AA 5 LEU A 66 ILE A 70 -1 N LEU A 67 O VAL A 79 SHEET 1 AB 3 GLN A 85 ASP A 86 0 SHEET 2 AB 3 LEU A 133 ASN A 136 -1 O ILE A 135 N GLN A 85 SHEET 3 AB 3 ALA A 140 LEU A 143 -1 O ALA A 140 N ASN A 136 SHEET 1 AC 2 VAL A 123 LEU A 124 0 SHEET 2 AC 2 ARG A 150 ALA A 151 -1 O ARG A 150 N LEU A 124 SHEET 1 CA 5 PHE C 4 GLY C 13 0 SHEET 2 CA 5 GLY C 16 ASN C 23 -1 O GLY C 16 N GLY C 13 SHEET 3 CA 5 VAL C 29 ARG C 36 -1 O VAL C 30 N ALA C 21 SHEET 4 CA 5 LYS C 75 GLU C 81 -1 O LEU C 76 N ILE C 35 SHEET 5 CA 5 LEU C 66 HIS C 71 -1 N LEU C 67 O VAL C 79 SHEET 1 CB 3 GLN C 85 ASP C 86 0 SHEET 2 CB 3 LEU C 133 ILE C 135 -1 O ILE C 135 N GLN C 85 SHEET 3 CB 3 ILE C 141 LEU C 143 -1 O LYS C 142 N LEU C 134 SHEET 1 CC 2 VAL C 123 LEU C 124 0 SHEET 2 CC 2 ARG C 150 ALA C 151 -1 O ARG C 150 N LEU C 124 LINK C TYR A 159 N TPO A 160 1555 1555 1.30 LINK C TPO A 160 N HIS A 161 1555 1555 1.34 LINK C TYR C 159 N TPO C 160 1555 1555 1.33 LINK C TPO C 160 N HIS C 161 1555 1555 1.34 LINK OD1 ASN A 132 MG MG A1298 1555 1555 2.02 LINK OD2 ASP A 145 MG MG A1298 1555 1555 2.38 LINK O2A ATP A1297 MG MG A1298 1555 1555 2.37 LINK O3B ATP A1297 MG MG A1298 1555 1555 2.15 LINK MG MG A1298 O3 NO3 A1299 1555 1555 2.28 LINK OD1 ASN C 132 MG MG C1299 1555 1555 1.95 LINK OD2 ASP C 145 MG MG C1299 1555 1555 2.52 LINK O2A ATP C1298 MG MG C1299 1555 1555 1.99 CISPEP 1 VAL A 154 PRO A 155 0 0.23 CISPEP 2 GLN B 323 PRO B 324 0 -4.95 CISPEP 3 ASP B 345 PRO B 346 0 -1.12 CISPEP 4 VAL C 154 PRO C 155 0 1.58 CISPEP 5 GLN D 323 PRO D 324 0 -5.66 CISPEP 6 ASP D 345 PRO D 346 0 1.92 SITE 1 AC1 14 ILE A 10 GLY A 13 ALA A 31 LYS A 33 SITE 2 AC1 14 GLU A 81 LEU A 83 ASP A 86 LYS A 89 SITE 3 AC1 14 GLN A 131 ASN A 132 LEU A 134 ASP A 145 SITE 4 AC1 14 MG A1298 NO3 A1299 SITE 1 AC2 4 ASN A 132 ASP A 145 ATP A1297 NO3 A1299 SITE 1 AC3 6 ASP A 127 ASN A 132 ASP A 145 ATP A1297 SITE 2 AC3 6 MG A1298 SER E 5 SITE 1 AC4 6 ARG B 211 ASP B 240 SER B 340 LEU B 341 SITE 2 AC4 6 LEU B 348 HOH B2030 SITE 1 AC5 5 MET B 246 ASN C 23 GLU C 28 ASP C 68 SITE 2 AC5 5 HOH C2048 SITE 1 AC6 14 GLY C 13 ALA C 31 LYS C 33 PHE C 80 SITE 2 AC6 14 GLU C 81 PHE C 82 LEU C 83 ASP C 86 SITE 3 AC6 14 GLN C 131 ASN C 132 ASP C 145 MG C1299 SITE 4 AC6 14 NO3 C1300 HOH C2022 SITE 1 AC7 4 ASN C 132 ASP C 145 ATP C1298 NO3 C1300 SITE 1 AC8 6 ASP C 127 LYS C 129 ASP C 145 ATP C1298 SITE 2 AC8 6 MG C1299 SER F 5 SITE 1 AC9 9 ASP A 127 LYS A 129 TPO A 160 GLU A 162 SITE 2 AC9 9 VAL A 164 THR A 165 NO3 A1299 HOH A2023 SITE 3 AC9 9 ILE B 270 SITE 1 BC1 19 TYR C 15 ARG C 50 ASP C 127 LYS C 129 SITE 2 BC1 19 LEU C 148 TPO C 160 GLU C 162 VAL C 163 SITE 3 BC1 19 VAL C 164 THR C 165 LEU C 166 TRP C 167 SITE 4 BC1 19 ARG C 169 GLY C 205 NO3 C1300 HOH C2030 SITE 5 BC1 19 GLU D 269 ILE D 270 HOH F2002 CRYST1 150.710 164.100 72.430 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006635 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006094 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013806 0.00000 MTRIX1 1 0.999950 0.007330 -0.006050 -0.28117 1 MTRIX2 1 0.007350 -0.999600 0.004110 155.81946 1 MTRIX3 1 -0.006020 -0.004150 -0.999970 36.73965 1